Semax
Nootropic peptide for cognitive enhancement and neuroprotection
14 views
Overview
Semax is a synthetic brain-boosting peptide developed in Russia, derived from a fragment of ACTH (a hormone that regulates stress response). It's one of the most well-researched nootropics, approved in Russia for stroke recovery and cognitive disorders. **What makes it special?** Semax increases BDNF (brain-derived neurotrophic factor) — essentially "fertilizer" for your brain that promotes the growth of new neurons and strengthens existing connections. **What the research shows:** • Enhances memory, focus, and learning capacity • Provides neuroprotection against oxidative stress and ischemia • May help with stroke recovery and optic nerve diseases • Shows antidepressant-like effects in studies • Supports nerve regeneration **How it works:** Semax modulates dopamine and serotonin systems while boosting BDNF. Unlike stimulants, it enhances cognition without causing jitters or crashes. **Typical use:** Administered as a nasal spray (usually 0.1% solution) for rapid absorption into the brain. Effects typically felt within 15-20 minutes. **N-Acetyl Semax:** An enhanced version with better blood-brain barrier penetration and potentially stronger effects. **Important to know:** Approved in Russia but not FDA-approved in the US. Research is promising but mostly from Russian institutions. --- **Sources:** Ashmarin IP, et al. (1997) Neuroscience and Behavioral Physiology | Dolotov OV, et al. (2006) Neuroscience

Quick Facts
Formula:C37H51N9O10S
Molecular Weight:813.93
Sequence:Met-Glu-His-Phe-Pro-Gly-Pro
Mechanism:ACTH analog with nootropic and neuroprotective effects
⚠️ Safety Information
Research compound only in most countries. Limited long-term safety data available.
Research Citations
Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice.
Liu R, Chen Y, Huang H, Li X, Lv J, Jiang L, Jiang H, Wu C, Chen W, Xu H, Zhu Z, Cai H, Xiao J, Yin L, Ni W (2025)
Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats.
Glazova NY, Manchenko DM, Volodina MA, Merchieva SA, Andreeva LA, Kudrin VS, Myasoedov NF, Levitskaya NG (2021)
Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models.
Sciacca MFM, Naletova I, Giuffrida ML, Attanasio F (2022)
+ 22 more citations